|
Market Cap (16-May) $246,695,168 (417th) |
Close (30-Jun) $1.23 |
Volume (30-Jun) 249,053 |
Shortsold (5-May) 39,772 (0.02%) (495th) |
|
52w High $2.09 |
52w Low $0.92 |
P/E - |
EPS -0.05 |
RAC released this announcement to the ASX on 20 April 2023, 9:23. The announcement is not marked as price sensitive, and is 2 page(s) in length and 102.37kb in size.
You can view all announcements from RAC and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAC was 0.000% short sold according to ASIC data. It was ranked the 629th most shorted stock on the ASX. It is now ranked as the 495th most shorted stock on the ASX with 0.023% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from RAC | |
|---|---|
| Notification of cessation of securities - RAC | 29 June 2023, 9:54 |
| Proposed issue of securities - RAC | 29 June 2023, 9:52 |
| Initial Director's Interest Notice | 29 June 2023, 9:46 |
| Race continues Board renewal - appoints new Chair | 20 April 2023, 9:23 |
| Race releases complete cardio-protection data & video | 14 April 2023, 9:06 |
| Race releases cardioprotection market potential data | 4 April 2023, 9:20 |
| Race Receives $1.48m R&D Tax Refund for Financial Year 2022 | 27 March 2023, 11:25 |
You must be logged in to post a reply.
Race Oncology 